The ATM expansion signals ongoing cash needs and likely continued dilution. With the stock trading at $1.75 and a $6M market cap, the $2.425M offering could pressure shares further. Monitor for accelerated ATM sales and any updates on cash runway or clinical milestones.
Price Chart
Executive Summary
Enveric Biosciences filed a 424B5 prospectus supplement to increase its ATM offering capacity by up to $2,425,000, bringing the total available under the shelf to $6,909,085.77. The company has already sold $3,199,400.98 through the ATM, and with a market cap of ~$6M, this additional potential dilution is significant.
Key Facts
- Enveric filed a 424B5 prospectus supplement to offer up to $2,425,000 in common stock via an ATM agreement with H.C. Wainwright.
- The company has already sold $3,199,400.98 of shares through the ATM as of the filing date.
- Total securities sold under General Instruction I.B.6 of Form S-3 in the prior 12 months is $4,483,711.04.
- The offering limit under I.B.6 is $6,909,085.77, leaving $2,425,000 in additional capacity.
- The company's market cap is approximately $6M, making the potential $2.425M offering represent roughly 40% dilution.
- The stock closed at $1.75 on June 8, 2026, the day before the filing.
Financial Impact
Potential additional dilution of up to $2,425,000, representing ~40% of the current $6M market cap.
Risk Factors
- Significant dilution risk as the ATM offering could increase share count by ~40% at current prices.
- Potential downward pressure on stock price as the ATM allows continuous selling into the market.
- The company has already sold $3.2M through the ATM, indicating persistent capital needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-027975 |
| Document: 0001493152-26-027975-index-headers.html | 0001493152-26-027975 |
| Document: 0001493152-26-027975-index.html | 0001493152-26-027975 |
| Document: 0001493152-26-027975.txt | 0001493152-26-027975 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 8-K | $1.48 $1.46 | ▲ +1.35% | ▼ −0.63% | $1.42 (+4.05%) |
Jun 9, 2026 20w ago | 8-K | $1.62 $1.43 | ▲ +11.73% | ▲ +15.35% | $1.42 (+12.35%) |
Jun 9, 2026 20w ago | 424B5 | $1.62 $1.43 | ▲ +11.73% | ▲ +15.35% | $1.42 (+12.35%) |
May 29, 2026 21w ago | 8-K | $2.26 $1.38 | ▲ +38.94% | ▲ +37.64% | $1.42 (+37.17%) |
May 15, 2026 23w ago | 8-K | $2.25 $1.48 | ▼ −34.22% | ▼ −36.34% | $1.42 (−36.89%) |
Apr 23, 2026 26w ago | S-3 | $5.04 $2.22 | ▲ +55.95% | ▲ +59.98% | $1.42 (+71.83%) |
Apr 14, 2026 28w ago | DEFA14A | $2.03 $2.52 | ▲ +24.14% | ▲ +18.09% | $1.42 (−30.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers